What is there to reason? That I should heed his points around...

What is there to reason? That I should heed his points around valuing based on EBITDA, when I've had an extensive career in the space, both from an M&A and investor position and would never and have never used such methods to value anything in the lending space....nor has anyone in any major tier 1 IB.... for that matter, every serious IB I spoken to thinks this share is ludicrously expensive too.

Rest assured, even if this stock dropped to 90 cents, I have no intention of buying it... I don't trade listed spec, I get in at seed... I am just hear to be a voice of reason, contrary to what you say, clearly yourself and Christos are being nowhere near as objective as I am.